Key Metrics
1.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
18
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
Q4
Oncology
SJR
- Q4 Oncology
- Q4 Histology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.7
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
2 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
64%
4 to 6 months
27%
7 to 9 months
0%
Above 9 months
9%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Rare case
- Systemic chemotherapy
- Rare tumor
- Gastrointestinal tract
- Soft tissue sarcoma
- Basal cell carcinoma
- Peritoneal mesothelioma
- Spindle cell carcinoma
- Germ cell tumors
- Prostate carcinoma
- Epithelioid hemangioendothelioma
- Insulinoma
- Molecular analysis
- Oral mucosa
- Overall survival
- Esophageal squamous cell carcinoma
- Surgical resection
- Synovial sarcoma
- Multiple Basal Cell Carcinomas
- Mixed Germ Cell Tumor
Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 895 |
| Publication Time | 15 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2009 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 15 |
| Article Processing Charges | USD 895 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in Rare Tumors ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Outcomes of pediatric extracranial germ cell tumors: A single center experience in a developing country.
- 1 Feb 24
- Rare Tumors
-
Full paper
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.
- 1 Feb 24
- Rare tumors
-
Full paper
Ewing's sarcoma of the parotid gland: A rare entity with review of the literature.
- 1 Feb 24
- Rare Tumors
-
Full paper
Novel MEN1-associated retroperitoneal pleomorphic liposarcoma.
- 1 Feb 24
- Rare tumors
-
Full paper
Large subserous uterine leiomyoma presenting as intraabdominal tumor: A case report.
- 1 Feb 24
- Rare tumors
-
Full paper
Real-world evidence for ultra rare cancers.
- 1 Feb 24
- Rare tumors
Scite analysis
Powered by scite_
672 articles received 5k citations see all
- 136 Supporting
- 4,598 Mentioning
- 18 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 3 Corrections
- 2 Errata
- 0 Expression of Concern
FAQs
How long has Rare Tumors been actively publishing?
Rare Tumors has been in operation since 2009 till date.
What is the publishing frequency of Rare Tumors ?
Rare Tumors published with a Continuous publication frequency.
How many articles did Rare Tumors publish last years ?
In 2023, Rare Tumors published 36 articles.
What is the eISSN & pISSN for Rare Tumors ?
For Rare Tumors,eISSN is 2036-3613 and pISSN is2036-3605.
What is Citescore for Rare Tumors ?
Citescore for Rare Tumors is 1.2.
What is H index for Rare Tumors ?
H index for Rare Tumors is 18.
What is SNIP score for Rare Tumors ?
SNIP score for Rare Tumors is 0.7.
What is the SJR for Rare Tumors ?
SJR for Rare Tumors is Q4.
Who is the publisher of Rare Tumors ?
SAGE PUBLICATIONS LTD is the publisher of Rare Tumors.